3′UTR/T polymorphism of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is associated with modified anti-platelet activity of atorvastatin in hypercholesterolemic subjects

Atherosclerosis

Volumn 183, Issue 2, 2005, Pages 322-328

  Puccetti, Luca ^a   Pasqui, Anna Laura ^a   Pastorelli, Marcello ^a   Ciani, Federica ^b   Palazzuoli, Alberto ^a   Gioffrè, Walter ^a   Auteri, Alberto ^a   Bruni, Fulvio ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b Unit of Neurometabolic Disorders   (Italy)

Author keywords

LOX 1 polymorphisms; Oxidized LDL; Platelets; Statins

Indexed keywords

ATORVASTATIN; CD36 ANTIGEN; LECTIN; LOW DENSITY LIPOPROTEIN RECEPTOR; OXIDIZED LOW DENSITY LIPOPROTEIN; PADGEM PROTEIN; RECEPTOR SUBTYPE; THROMBIN; CITRULLINE; DNA; HEPTANOIC ACID DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT; NITRIC OXIDE SYNTHASE; OLR1 PROTEIN, HUMAN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PYRROLE DERIVATIVE;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOFLUOROMETRY; DNA POLYMORPHISM; DRUG ACTIVITY; FEMALE; GENE EXPRESSION; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION INHIBITION; ALLELE; BLOOD; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRACELLULAR FLUID; METABOLISM; MIDDLE AGED; POLYMERASE CHAIN REACTION; THROMBOCYTE;

ADULT; ALLELES; ANTICHOLESTEREMIC AGENTS; BLOOD PLATELETS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CITRULLINE; DNA; FEMALE; GENOTYPE; HEPTANOIC ACIDS; HUMANS; HYPERCHOLESTEROLEMIA; INTRACELLULAR FLUID; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; P-SELECTIN; PLATELET ACTIVATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PYRROLES; SCAVENGER RECEPTORS, CLASS E;

EID: 27544478865     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.03.012     Document Type: Article

References (31)

1. C. Bolego, R. Baetta, S. Bellosta, A. Corsini, and R. Paoletti Safety considerations for statins Curr Opin Lipidol 13 2002 637 664
2. C.J. Vaughan, A.M. Gotto Jr., and C.T. Basson The evolving role of statins in the management of atherosclerosis J Am Coll Cardiol 35 1999 1 10
3. C. Comparato, C. Altana, and S. Bellosta Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction? Nutr Metab Cardiovasc Dis 11 2001 328 343
4. V. Fuster, L. Badimon, J.J. Badimon, and J.H. Chesebro The pathogenesis of coronary artery disease and the acute coronary syndromes N Engl J Med 326 1992 242 250
5. A. Notarbartolo, G. Davì, and M. Averna Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia Artrioscler Thromb Vasc Biol 15 1995 247 251
6. L. Puccetti, A.L. Pasqui, and M. Pastorelli Platelet hyperactivity after statin treatment discontinuation Thromb Haemost 90 2003 476 482
7. L. Puccetti, A.L. Pasqui, and M. Pastorelli Time-dependent effect of statins on platelet function in hypercholesterolemic subjects Eur J Clin Invest 32 2002 901 908
8. L.Y. Chen, P. Metha, and J.L. Metha Oxidized LDL decreases l-arginine uptake and nitric oxide synthase protein expression in human platelets. Relevance of the effect of oxidized LDL on platelet function Circulation 93 1996 1740 1746
9. 2+-ATPase Cell Calcium 19 1996 453 458
10. M. Retzer, W. Siess, and M. Essler Mildly oxidized low density lipoprotein induces platelet shape change via Rho-kinase-dependent phosphorylation of myosin light chain and moesin FEBS Lett 446 2000 70 74
11. L. Puccetti, T. Sawamura, and A.L. Pasqui Effect of statins on platelet oxidized-LDL receptors expression in hypercholesterolemic subjects Eur J Clin Invest 35 2005 47 51
12. T. Sawamura, N. Kume, and T. Aoyama An endothelial receptor for oxidized low-density lipoprotein Nature 386 1997 73 77
13. H. Yoshida, N. Kondratenko, S. Green, D. Steinberg, and O. Quehenberger Identification of the lectin-like receptor of oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor Biochem J 334 1998 9 13
14. M. Chen, M. Kakutani, and T. Narudo Activation-dependent surface expression of LOX-1 in human platelets Biochem Biophys Res Commun 282 2001 153 158
15. J.L. Metha, and D. Li Identification, regulation and function of a novel lectin-like oxidized low-density lipoprotein receptor J Am Coll Cardiol 39 2002 1429 1435
16. K. Sakurai, and T. Sawamura Endothelial dysfunction via lectin-like oxidized low-density lipoprotein receptor-1: close relationship with oxidative stress J Pharmacol Sci 91 2003 182 186
17. L. Cominacini, A. Fratta Pasini, and U. Garbin The platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells J Am Coll Cardiol 41 2003 499 507
18. J.L. Metha, D.Y. Li, H.J. Chen, J. Joseph, and F. Romeo Inhibition of LOX-1 by statins may relate to upregulation of eNOS Biochem Biophys Res Commun 289 2001 857 861
19. R. Mango, F. Clementi, and P. Borgiani Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction J Med Genet 40 2003 933 936
20. Q. Chen, S.E. Reis, and C. Kammerer Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery disease Circulation 107 2003 3146 3151
21. M. Tatsuguchi, M. Furutani, and J.I. Hinagata Oxidized LDL receptor gene (OLR1) is associated with the risk of myocardial infarction Biochem Biophys Res Commun 303 2003 247 250
22. G. Endemann, L.W. Stanton, and K.S. Maden CD36 is a receptor for oxidized low-density lipoprotein J Biol Chem 268 1993 11811 11816
23. M. Imai, T. Tanaka, and T. Kintaka Genomic heterogeneity of type II CD36 deficiency Clin Chim Acta 321 2002 97 106
24. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adults treatment panel III) JAMA 285 2001 2486 2497
25. J.C. Plana, and P.H. Jones The use of statins in acute coronary syndromes: the mechanisms behind the outcomes Curr Atheroscler Rep 3 2001 355 364
26. A.D. Blann, S.K. Nadar, and GY.H. Lip The adhesion molecule P-selectin and cardiovascular disease Eur Heart J 24 2003 2166 2179
27. M. Chen, S. Narumiya, T. Masaki, and T. Sawamura Conserved C-terminal residues within the lectin-like domain of LOX-1 are essential for oxidized-low-density-lipoprotein binding Biochem J 355 2001 289 296
28. K.B. Holven, H. Scholz, and B. Halvorsen Hyperhomocysteinemic subjects have enhanced expression of lectin-like oxidized LDL receptor-1 in mononuclear cells J Nutr 133 2003 3588 3591
29. O. Hofnagel, B. Luechtenborg, and K. Stolle Proinflammatory cytokines regulate LOX-1 expression in vascular smooth muscle cells Arterioscler Thromb Vasc Biol 24 2004 1789 1795
30. R.S. Rosenson Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities Atherosclerosis 170 2004 1 12
31. D.I. Chasman, D. Posada, and L. Subrahmanyan Pharmacogenetic study of statin therapy and cholesterol reduction JAMA 291 2004 2821 2827